SBIO.L vs. BTEK.L
Compare and contrast key facts about Invesco Nasdaq Biotech UCITS ETF (SBIO.L) and iShares Nasdaq US Biotechnology UCITS ETF (BTEK.L).
SBIO.L and BTEK.L are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. SBIO.L is a passively managed fund by Invesco that tracks the performance of the NASDAQ Biotechnology TR USD. It was launched on Nov 6, 2014. BTEK.L is a passively managed fund by iShares that tracks the performance of the NASDAQ Biotechnology TR USD. It was launched on Oct 19, 2017. Both SBIO.L and BTEK.L are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: SBIO.L or BTEK.L.
Correlation
The correlation between SBIO.L and BTEK.L is 0.96, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Performance
SBIO.L vs. BTEK.L - Performance Comparison
Key characteristics
SBIO.L:
0.18
BTEK.L:
0.20
SBIO.L:
0.36
BTEK.L:
0.40
SBIO.L:
1.05
BTEK.L:
1.05
SBIO.L:
0.13
BTEK.L:
0.21
SBIO.L:
0.52
BTEK.L:
0.67
SBIO.L:
6.23%
BTEK.L:
5.13%
SBIO.L:
18.39%
BTEK.L:
16.92%
SBIO.L:
-39.44%
BTEK.L:
-30.86%
SBIO.L:
-14.19%
BTEK.L:
-6.19%
Returns By Period
In the year-to-date period, SBIO.L achieves a 7.15% return, which is significantly higher than BTEK.L's 6.36% return.
SBIO.L
7.15%
4.16%
-5.49%
4.48%
4.04%
2.98%
BTEK.L
6.36%
1.39%
-1.12%
4.53%
4.56%
N/A
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
SBIO.L vs. BTEK.L - Expense Ratio Comparison
SBIO.L has a 0.40% expense ratio, which is higher than BTEK.L's 0.35% expense ratio.
Risk-Adjusted Performance
SBIO.L vs. BTEK.L — Risk-Adjusted Performance Rank
SBIO.L
BTEK.L
SBIO.L vs. BTEK.L - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Invesco Nasdaq Biotech UCITS ETF (SBIO.L) and iShares Nasdaq US Biotechnology UCITS ETF (BTEK.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
SBIO.L vs. BTEK.L - Dividend Comparison
Neither SBIO.L nor BTEK.L has paid dividends to shareholders.
Drawdowns
SBIO.L vs. BTEK.L - Drawdown Comparison
The maximum SBIO.L drawdown since its inception was -39.44%, which is greater than BTEK.L's maximum drawdown of -30.86%. Use the drawdown chart below to compare losses from any high point for SBIO.L and BTEK.L. For additional features, visit the drawdowns tool.
Volatility
SBIO.L vs. BTEK.L - Volatility Comparison
Invesco Nasdaq Biotech UCITS ETF (SBIO.L) has a higher volatility of 5.20% compared to iShares Nasdaq US Biotechnology UCITS ETF (BTEK.L) at 4.93%. This indicates that SBIO.L's price experiences larger fluctuations and is considered to be riskier than BTEK.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.